Enteric fever, encompassing both typhoid and paratyphoid fever, remains a significant global health concern. Despite advances in diagnostic methods and treatment regimens, the disease continues to pose challenges due to evolving antibiotic resistance and non-specific clinical presentation. This article outlines the latest approach to diagnosing and treating enteric fever.
Diagnosis of enteric fever has traditionally relied on blood culture, which remains the gold standard. However, its sensitivity varies from 40-80%, necessitating the need for more accurate tests. Molecular diagnostic techniques, such as polymerase chain reaction (PCR), offer higher sensitivity and specificity. Novel rapid diagnostic tests (RDTs) based on antigen detection are also promising, with the Typhidot test showing considerable utility in resource-limited settings.
The rise of multi-drug resistant (MDR) and extensively drug-resistant (XDR) strains of Salmonella Typhi has made treatment more complex. Fluoroquinolones, once the drug of choice, are now less effective due to resistance. Current guidelines recommend using third-generation cephalosporins like ceftriaxone or cefixime, or azithromycin as first-line treatment. In cases of XDR strains, carbapenems or azithromycin are recommended.
Vaccination remains a key preventive measure. The World Health Organization recommends the typhoid conjugate vaccine (TCV) for children over six months in endemic areas. The older Vi polysaccharide vaccine is recommended for travellers to endemic areas, but does not provide long-term protection like TCV.
Enteric fever continues to be a global health challenge. Accurate diagnosis is pivotal and can be enhanced with molecular techniques and RDTs. Treatment is complicated by increasing antibiotic resistance, necessitating vigilant antibiotic stewardship. Vaccination remains a crucial component of prevention. As healthcare professionals, staying abreast of these evolving strategies is essential in managing this persistent disease.
1.
Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?
2.
The need for more Latinx participants in Alzheimer's trials is urgent.
3.
Admissions, medical colleges, fees, and eligibility requirements information for the DNB Post Diploma in Radiation Oncology.
4.
Study identifies new approach to protect the brain during radiation therapy
5.
Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD
1.
CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review
2.
Treating Oral Fibromas: Options and Guidelines for a Healthier Mouth
3.
The Genetics of Bernard Soulier Syndrome: What We Know so Far
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
Unlocking The Power Of Cangrelor To Treat Heart Disease
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
3.
Navigating the Complexities of Ph Negative ALL - Part XV
4.
Lung Cancer: Risk Factors and Prevention
5.
Thromboprophylaxis In Medical Settings
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation